Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Jan 15, 2023; 15(1): 171-185
Published online Jan 15, 2023. doi: 10.4251/wjgo.v15.i1.171
Published online Jan 15, 2023. doi: 10.4251/wjgo.v15.i1.171
Genetic comparison | Population | OR (95%CI) | P value | Test of heterogeneity | Model | Power value | |
P value | I2 | ||||||
C vs T | All | 1.21 (1.03-1.41) | 0.019 | < 0.001 | 74.9% | R | 1.000 |
Ethnicity | |||||||
Asians | 1.32 (1.06-1.64) | 0.013 | < 0.001 | 79.4% | R | 1.000 | |
Caucasians | 1.06 (0.86-1.32) | 0.586 | 0.010 | 64.2% | R | - | |
Study design | |||||||
HB | 1.25 (1.01-1.54) | 0.039 | < 0.001 | 79.0% | R | 0.999 | |
PB | 1.13 (0.90-1.42) | 0.285 | 0.027 | 63.6% | R | - | |
Controls | |||||||
Normal or healthy control | 1.22 (1.02-1.48) | 0.034 | < 0.001 | 77.2% | R | 0.998 | |
Hepatitis or virus related control | 1.27 (1.07-1.52) | 0.007 | 0.192 | 39.4% | F | 0.785 | |
NA | 0.71 (0.49-1.04) | 0.080 | - | - | - | - | |
Nos quality assessment | |||||||
≥ 7.0 | 1.24 (0.97-1.58) | 0.088 | < 0.001 | 81.2% | R | ||
< 7.0 | 1.17 (0.96-1.43) | 0.216 | 0.004 | 66.2% | R | ||
CC vs TT | All | 1.33 (0.98-1.80) | 0.071 | 0.002 | 57.3% | R | - |
Ethnicity | |||||||
Asians | 1.48 (0.97-2.26) | 0.073 | 0.021 | 54.0% | R | - | |
Caucasians | 1.16 (0.72-1.87) | 0.534 | 0.008 | 65.3% | R | - | |
Study design | |||||||
HB | 1.44 (0.97-2.16) | 0.074 | < 0.001 | 67.7% | R | - | |
PB | 1.20 (0.83-1.73) | 0.344 | 0.551 | 0.0% | F | - | |
Controls | |||||||
Normal or healthy control | 1.31 (0.88-1.93) | 0.183 | 0.001 | 62.8% | R | - | |
Hepatitis or virus related control | 1.56 (1.10-2.23) | 0.014 | 0.329 | 10.1% | F | 0.725 | |
NA | 0.47 (0.12-1.87) | 0.285 | - | - | - | - | |
Nos quality assessment | |||||||
≥ 7.0 | 1.26 (0.71-2.25) | 0.436 | 0.02 | 67.3% | R | ||
< 7.0 | 1.41 (1.01-1.96) | 0.014 | 0.086 | 43.8% | R | 0.881 | |
CC/CT vs TT | All | 1.26 (1.04-1.51) | 0.016 | < 0.001 | 70.0% | R | 0.999 |
Ethnicity | |||||||
Asians | 1.34 (1.06-1.71) | 0.016 | < 0.001 | 75.7% | R | 0.999 | |
Caucasians | 1.12 (0.83-1.51) | 0.468 | 0.021 | 59.7% | R | - | |
Study design | |||||||
HB | 1.32 (1.03-1.70) | 0.031 | < 0.001 | 73.1% | R | 0.999 | |
PB | 1.16 (0.87-1.54) | 0.309 | 0.014 | 67.9% | R | - | |
Controls | |||||||
Normal or healthy control | 1.29 (1.03-1.60) | 0.024 | < 0.001 | 72.5% | R | 0.999 | |
Hepatitis or virus related control | 1.37 (1.06-1.77) | 0.018 | 0.397 | 0.0% | F | 0.697 | |
NA | 0.68 (0.44-1.05) | 0.084 | - | - | - | - | |
Nos quality assessment | |||||||
≥ 7.0 | 1.33 (1.01-1.76) | 0.044 | < 0.001 | 78.2% | R | 0.997 | |
< 7.0 | 1.18 (0.92-1.51) | 0.191 | 0.026 | 56.1% | R | ||
CC vs TT/CT | All | 1.21 (0.96-1.53) | 0.109 | 0.049 | 39.4% | R | - |
Ethnicity | |||||||
Asians | 1.37 (0.95-1.97) | 0.095 | 0.077 | 42.1% | R | - | |
Caucasians | 1.09 (0.87-1.37) | 0.448 | 0.127 | 39.6% | F | - | |
Study design | |||||||
HB | 1.25 (0.93-1.70) | 0.145 | 0.014 | 53.7% | R | - | |
PB | 1.15 (0.80-1.65) | 0.449 | 0.640 | 0.0% | F | - | |
Controls | |||||||
Normal or healthy control | 1.18 (0.87-1.60) | 0.284 | 0.029 | 47.5% | R | - | |
Hepatitis or virus related control | 1.36 (0.99-1.87) | 0.061 | 0.421 | 0.0% | F | - | |
NA | 0.53 (0.14-2.10) | 0.368 | - | - | - | - | |
Nos quality assessment | |||||||
≥ 7.0 | 1.08 (0.68-1.71) | 0.744 | 0.027 | 53.7% | R | ||
< 7.0 | 1.30 (1.05-1.60) | 0.017 | 0.284 | 18.5% | F | 0.734 |
- Citation: Jiang JK, Chen HS, Tang WF, Chen Y, Lin J. Rs3746444 T>C locus in miR-499 increases the susceptibility to hepatocellular carcinoma: A meta-analysis 14812 subjects. World J Gastrointest Oncol 2023; 15(1): 171-185
- URL: https://www.wjgnet.com/1948-5204/full/v15/i1/171.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i1.171